##gff-version 3
##sequence-region Q92841 1 729
Q92841	UniProtKB	Chain	1	729	.	.	.	ID=PRO_0000054993;Note=Probable ATP-dependent RNA helicase DDX17	
Q92841	UniProtKB	Domain	202	377	.	.	.	Note=Helicase ATP-binding;Ontology_term=ECO:0000255;evidence=ECO:0000255|PROSITE-ProRule:PRU00541	
Q92841	UniProtKB	Domain	405	552	.	.	.	Note=Helicase C-terminal;Ontology_term=ECO:0000255;evidence=ECO:0000255|PROSITE-ProRule:PRU00542	
Q92841	UniProtKB	Nucleotide binding	215	222	.	.	.	Note=ATP;Ontology_term=ECO:0000255;evidence=ECO:0000255|PROSITE-ProRule:PRU00541	
Q92841	UniProtKB	Region	547	729	.	.	.	Note=Transactivation domain	
Q92841	UniProtKB	Region	718	726	.	.	.	Note=Interaction with YAP1;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:24581491;Dbxref=PMID:24581491	
Q92841	UniProtKB	Motif	171	199	.	.	.	Note=Q motif	
Q92841	UniProtKB	Motif	325	328	.	.	.	Note=DEAD box	
Q92841	UniProtKB	Compositional bias	101	104	.	.	.	Note=Poly-Gly	
Q92841	UniProtKB	Compositional bias	556	563	.	.	.	Note=Poly-Gly	
Q92841	UniProtKB	Compositional bias	718	726	.	.	.	Note=Poly-Pro	
Q92841	UniProtKB	Modified residue	64	64	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244,ECO:0000244;evidence=ECO:0000244|PubMed:20068231,ECO:0000244|PubMed:24275569;Dbxref=PMID:20068231,PMID:24275569	
Q92841	UniProtKB	Modified residue	108	108	.	.	.	Note=N6-acetyllysine%3B by EP300;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:20663877;Dbxref=PMID:20663877	
Q92841	UniProtKB	Modified residue	109	109	.	.	.	Note=N6-acetyllysine%3B by EP300;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:20663877;Dbxref=PMID:20663877	
Q92841	UniProtKB	Modified residue	121	121	.	.	.	Note=N6-acetyllysine%3B by EP300;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:20663877;Dbxref=PMID:20663877	
Q92841	UniProtKB	Modified residue	523	523	.	.	.	Note=Phosphothreonine;Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:16964243;Dbxref=PMID:16964243	
Q92841	UniProtKB	Modified residue	684	684	.	.	.	Note=Omega-N-methylarginine;Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:24129315;Dbxref=PMID:24129315	
Q92841	UniProtKB	Cross-link	129	129	.	.	.	Note=Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO)%3B alternate	
Q92841	UniProtKB	Cross-link	129	129	.	.	.	Note=Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1)%3B alternate;Ontology_term=ECO:0000244,ECO:0000269;evidence=ECO:0000244|PubMed:25114211,ECO:0000269|PubMed:19995069;Dbxref=PMID:25114211,PMID:19995069	
Q92841	UniProtKB	Cross-link	129	129	.	.	.	Note=Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)%3B alternate;Ontology_term=ECO:0000244,ECO:0000244,ECO:0000244,ECO:0000244;evidence=ECO:0000244|PubMed:25218447,ECO:0000244|PubMed:25755297,ECO:0000244|PubMed:25772364,ECO:0000244|PubMed:28112733;Dbxref=PMID:25218447,PMID:25755297,PMID:25772364,PMID:28112733	
Q92841	UniProtKB	Cross-link	528	528	.	.	.	Note=Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2);Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:28112733;Dbxref=PMID:28112733	
Q92841	UniProtKB	Alternative sequence	1	79	.	.	.	ID=VSP_042527;Note=In isoform 2%2C isoform 3 and isoform 4. Missing;Ontology_term=ECO:0000303,ECO:0000303,ECO:0000303;evidence=ECO:0000303|PubMed:15461802,ECO:0000303|PubMed:17974005,ECO:0000303|PubMed:8871553;Dbxref=PMID:15461802,PMID:17974005,PMID:8871553	
Q92841	UniProtKB	Alternative sequence	482	482	.	.	.	ID=VSP_042528;Note=In isoform 3. L->LGL;Ontology_term=ECO:0000303;evidence=ECO:0000303|PubMed:17974005;Dbxref=PMID:17974005	
Q92841	UniProtKB	Alternative sequence	562	562	.	.	.	ID=VSP_042529;Note=In isoform 4. G->GKG;Ontology_term=ECO:0000303;evidence=ECO:0000303|PubMed:15461802;Dbxref=PMID:15461802	
Q92841	UniProtKB	Mutagenesis	108	109	.	.	.	Note=No effect on HDAC1-%2C HDAC2- nor HDAC3-binding%2C small decrease in ESR1 coactivation%2C decreased TP53 coactivation. Complete loss of lysine acetylation%2C decreased stability%2C loss of ESR1 and TP53 coactivation and loss of HDAC1- and HDAC3-binding%2C no effect on HDAC2-binding%3B when associated with R-121. KK->RR;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:20663877;Dbxref=PMID:20663877	
Q92841	UniProtKB	Mutagenesis	121	121	.	.	.	Note=No effect on HDAC1-%2C HDAC2- nor HDAC3-binding%2C decreased ESR1 coactivation%2C strongly decreased TP53 coactivation. Complete loss of lysine acetylation%2C decreased stability%2C loss of ESR1 and TP53 coactivation and loss of HDAC1- and HDAC3-binding%2C no effect on HDAC2-binding%3B when associated with 108-R-R-109. K->R;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:20663877;Dbxref=PMID:20663877	
Q92841	UniProtKB	Mutagenesis	129	129	.	.	.	Note=Impaired sumoylation and decreased stability. Impairs interaction with HDAC1%2C but not with HDAC2%2C nor HDAC3. No effect on EP300-%2C ESR1-%2C DDX5- and YAP1-binding. K->R;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:19995069,ECO:0000269|PubMed:24581491;Dbxref=PMID:19995069,PMID:24581491	
Q92841	UniProtKB	Mutagenesis	221	221	.	.	.	Note=No effect on transcription activation%2C when assayed in luciferase reporter gene assays using MDM2 or FOS promoters%2C either alone or in the presence of EP300 and KAT2B. K->N;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:17226766;Dbxref=PMID:17226766	
Q92841	UniProtKB	Mutagenesis	221	221	.	.	.	Note=Loss of helicase activity. Loss of splicing regulation in the estrogen signaling pathway. Reduced CD44 alternative splicing regulation. Does not promote ZCH3HAV1-mediated RNA degradation. K->R;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:12138182,ECO:0000269|PubMed:18334637,ECO:0000269|PubMed:24275493;Dbxref=PMID:12138182,PMID:18334637,PMID:24275493	
Q92841	UniProtKB	Mutagenesis	222	222	.	.	.	Note=Decreased CD44 alternative splicing. T->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:12138182;Dbxref=PMID:12138182	
Q92841	UniProtKB	Mutagenesis	325	325	.	.	.	Note=Loss of helicase activity. No effect on ESR1 coactivation. D->N;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:19718048;Dbxref=PMID:19718048	
Q92841	UniProtKB	Mutagenesis	328	328	.	.	.	Note=Small decrease in CD44 alternative splicing. D->H;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:12138182;Dbxref=PMID:12138182	
Q92841	UniProtKB	Mutagenesis	355	355	.	.	.	Note=Small decrease in CD44 alternative splicing. W->G;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:12138182;Dbxref=PMID:12138182	
Q92841	UniProtKB	Mutagenesis	356	356	.	.	.	Note=Small decrease in CD44 alternative splicing. S->L;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:12138182;Dbxref=PMID:12138182	
